XORTX Therapeutics (XRTX) FCF Margin (2023)
XORTX Therapeutics (XRTX) FCF Margin (2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.96 Bn | 132.11 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 86.79 Bn | 78.79 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 65.22 Bn | 60.03 Bn | 1.37 Bn | - |
| 4 | Moderna | 60.20 Bn | 55.06 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 42.19 Bn | 37.09 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 31.43 Bn | 28.12 Bn | 992.69 Mn | 22.62% |
| 7 | BioNTech SE | 28.65 Bn | 10.26 Bn | 668.28 Mn | 41.07% |
| 8 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -22.35% |
| 9 | Royalty Pharma | 27.16 Bn | 26.32 Bn | - | 70.82% |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 0.13% |
| Mar 31, 2023 | 0.15% |